# Lisdexamfetamine dimesylate

NDC: 43547-602
Generic name: Lisdexamfetamine dimesylate capsules
Labeler / Manufacturer: Solco Healthcare US,LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230826

FDA application: ANDA216266

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43547-602"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43547-602
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68b10d9f-ca3e-493d-a309-45f1d7e08061